NeoGenomics, Inc. (NEO) Investment Research Dashboard
About NeoGenomics, Inc. (NEO) stock analysis
Get live NEO stock price $13.55, comprehensive NeoGenomics, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time NEO stock data and investment insights.
Loading chart data...
NeoGenomics, Inc. (NEO) Overview
NeoGenomics, Inc. (NEO) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, NEO trades at $13.55 with a market capitalization of 353.00M . Over the past 52 weeks, NEO has traded between $4.72 and $15.57 , with the current price positioned at approximately 81% of this range . The stock curre...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 353.00M
- Current price: $13.55
- 52-week range: $4.72 - $15.57
- P/E ratio: 104.27
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical S...
Company Information
- CEO
- Anthony Zook
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 2500
Contact Information
- Website
- https://www.neogenomics.com
- Address
- 9490 NeoGenomics Way
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 104.3)
✓ Higher growth potential with elevated volatility (Beta: 1.74)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for NeoGenomics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for NeoGenomics, Inc.
- ⚠Investors should consider how NeoGenomics, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 104.3) requires strong growth to justify
Market Cap
353.00M
P/E Ratio (TTM)
104.27
Beta
1.74
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
81/100 ⭐⭐⭐⭐⭐
- Overall
- +0.3%
- NYSE
- -0.1%
- NASDAQ
- +0.8%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.1% | +1.3% | +2.0% | 19.3 | 82/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.3% | +2.8% | +1.6% | 23.6 | 81/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.8% | -2.0% | +2.3% | 22.2 | 70/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | +1.1% | +1.3% | +0.1% | 29.0 | 66/100⭐⭐⭐⭐ |
| Energy | +0.9% | +0.7% | -1.3% | 19.7 | 64/100⭐⭐⭐⭐ |
| Real Estate | -0.4% | +2.3% | -1.5% | 29.6 | 54/100⭐⭐⭐ |
| Basic Materials | -0.4% | +0.7% | -1.5% | 25.0 | 46/100⭐⭐⭐ |
| Utilities | -1.0% | +2.2% | -2.2% | 25.6 | 44/100⭐⭐⭐ |
| Consumer Cyclical | +0.5% | -1.4% | -3.8% | 42.9 | 18/100⭐ |
| Industrials | -0.8% | -0.4% | -9.2% | 30.6 | 13/100⭐ |
| Technology | -1.9% | -1.1% | -5.6% | 42.0 | 12/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-27.